Administrative Core
行政核心
基本信息
- 批准号:10230142
- 负责人:
- 金额:$ 0.45万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1998
- 资助国家:美国
- 起止时间:1998-02-18 至 2022-01-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAreaAwardBasic ScienceBudgetsBusinessesCLC GeneCancer CenterCancer Center Support GrantCatchment AreaChestClinicalClinical ResearchClinical SciencesCollaborationsCommittee MembersCommittee MembershipCommunicationCountyCutaneousDevelopmentEducationEffectivenessElectronic MailEnsureEvaluationFacultyFaculty RecruitmentFloridaFosteringFrequenciesFundingFunding OpportunitiesGoalsGrantGrant ReviewHematologic NeoplasmsHourHuman PapillomavirusInformation TechnologyInfrastructureInterest GroupIntervention StudiesInvestmentsJointsLeadershipLinkMagnetic Resonance ImagingMalignant NeoplasmsMentorsMentorshipMonitorNewsletterPerformancePhilanthropic FundPoliciesPopulationPopulation SciencesPositioning AttributePreventionProcessReportingResearchResearch SupportResource SharingResourcesReview CommitteeRoleScienceScientistSeriesSignal TransductionStrategic PlanningStructureTechnologyTechnology TransferTimeTrainingTraining ActivityTraining and EducationTranslational ResearchTranslationsUnderrepresented GroupsVisionWorkexperiencefaculty supportfarm workerinnovationmeetingsmemberoperationprogramsrecruitresearch and developmentsatisfaction
项目摘要
PROJECT SUMMARY
Moffitt Cancer Center Administration includes the Research Executive Committee (REX), Scientific Leadership
Committee (SLC), and Research Administration. REX establishes the overall scientific direction of the Center
through strategic planning investment, evaluation, and nimble, coordinated activities that take advantage of
unique opportunities or that address problems. Research Administration operationalizes and supports this
vision. REX members include the Center Director and the six Associate Center Directors (ACDs) of Basic,
Clinical, Population, and Translational Sciences; Education & Training; and Research Administration. This
committee meets weekly for one and a half to two hours. This frequency ensures that activities related to
recruitment, research development (including the Grant Review Committee, GRC), planning, space, academic
affairs, and policy are rapidly addressed, while fostering a highly collaborative and integrated culture. The REX
members are all highly productive scientists and leaders; collectively they have more than 110 years of Cancer
Center leadership experience. SLC includes REX plus Program Leaders and Center of Excellence
(transdisciplinary interest groups) Leaders. This group advises the Director and REX, with subcommittees for
shared resources (Core Leadership Committee, CLC), member evaluation (Membership Committee, MC),
clinical science (Clinical Research Action Committee, CRAC), and technology transfer/development
(Innovation & Technology Committee, ITC).
CCSG Research Administration is composed of 68 (only 2.6 FTE requested) staff members that support
Moffitt's 142 Members, 698 other staff, and 13 shared resources. Reporting to the ACD of Research
Administration, the administrative unit includes three Senior Directors, five Directors, four Managers, and their
teams. Administration assists the Center Director in the ongoing research strategic planning and evaluation
process; regular member and staff communications; faculty recruitment; shared resource oversight, including
chargebacks, performance review, and user satisfaction; managing the $145 million annual budget, including
philanthropic funds; awarding and monitoring more than $2 million in annual institutionally-supported
developmental awards; managing and implementing MCC policies for 333,000-sf of dedicated research space;
conducting the quarterly membership review and monitoring process; and arranging and documenting
approximately 150 Center meetings and retreats per year. The current budget requests for Senior Leadership
and Administration are $174,034 (9% of CCSG budget) and $153,888 (8% of CCSG budget), respectively.
Collectively this represents less than 0.3% of the overall institutional research budget.
项目摘要
莫菲特癌症中心管理局包括研究执行委员会(REX),科学领导
委员会(SLC)和研究管理局。雷克斯建立了中心的整体科学方向
通过战略规划投资,评估和敏捷的协调活动,利用
独特的机会或解决问题。研究管理局运作并支持这一点
想象。雷克斯成员包括中心主任和基本的六个副主任(ACD),
临床,人口和翻译科学;教育与培训;和研究管理局。这
委员会每周开会一个半至两个小时。此频率可确保与
招聘,研究开发(包括赠款审查委员会,GRC),规划,空间,学术
事务和政策得到迅速解决,同时培养了一种高度协作和综合的文化。雷克斯
成员都是高产的科学家和领导者。他们共有110年以上的癌症
中心领导经验。 SLC包括Rex Plus计划负责人和卓越中心
(跨学科利益集团)领导人。该小组向董事和雷克斯(Rex)建议
共享资源(核心领导委员会,CLC),会员评估(会员委员会,MC),
临床科学(CRAC临床研究行动委员会)和技术转移/开发
(创新与技术委员会,ITC)。
CCSG研究管理局由支持支持的68名(仅要求2.6 FTE)组成
莫菲特(Moffitt)的142名成员,其他698名员工和13个共享资源。向研究的ACD报告
行政部门,行政部门包括三名高级董事,五名董事,四名经理及其
团队。行政管理协助中心主任正在进行的研究战略规划和评估
过程;常规会员和员工沟通;教师招聘;共享资源监督,包括
退款,绩效审查和用户满意度;管理1.45亿美元的年度预算,包括
慈善基金;授予和监视超过200万美元的年度机构支持
发展奖;管理和实施333,000-SF专用研究空间的MCC政策;
进行季度会员审查和监控过程;以及安排和记录
每年约有150次中心会议和务虚会。当前的预算要求高级领导
管理分别为174,034美元(占CCSG预算的9%)和153,888美元(占CCSG预算的8%)。
总体而言,这占整体研究预算的0.3%。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
John L. Cleveland其他文献
Oncogenes: clinical relevance.
癌基因:临床相关性。
- DOI:
10.1007/978-3-642-72624-8_97 - 发表时间:
1987 - 期刊:
- 影响因子:0
- 作者:
Ulf R. Rapp;Stephen M. Storm;John L. Cleveland - 通讯作者:
John L. Cleveland
raf family serine/threonine protein kinases in mitogen signal transduction.
raf 家族丝氨酸/苏氨酸蛋白激酶在丝裂原信号转导中的作用。
- DOI:
- 发表时间:
1988 - 期刊:
- 影响因子:0
- 作者:
Ulf R. Rapp;Gisela Heidecker;Mahmoud Huleihel;John L. Cleveland;W. C. Choi;T. Pawson;James N. Ihle;W. Anderson - 通讯作者:
W. Anderson
Activation of Apoptosis Associated With Enforced <em>Myc</em> Expression in Myeloid Progenitor Cells Is Dominant to the Suppression of Apoptosis by Interleukin-3 or Erythropoietin
- DOI:
10.1182/blood.v82.7.2079.2079 - 发表时间:
1993-10-01 - 期刊:
- 影响因子:
- 作者:
David S. Askew;James N. Ihle;John L. Cleveland - 通讯作者:
John L. Cleveland
John L. Cleveland的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('John L. Cleveland', 18)}}的其他基金
New Therapeutic Vulnerabilities for Aggressive B-Cell Lymphoma
侵袭性 B 细胞淋巴瘤的新治疗漏洞
- 批准号:
10153731 - 财政年份:2020
- 资助金额:
$ 0.45万 - 项目类别:
New Therapeutic Vulnerabilities for Aggressive B-Cell Lymphoma
侵袭性 B 细胞淋巴瘤的新治疗漏洞
- 批准号:
10405450 - 财政年份:2020
- 资助金额:
$ 0.45万 - 项目类别:
New Therapeutic Vulnerabilities for Aggressive B-Cell Lymphoma
侵袭性 B 细胞淋巴瘤的新治疗漏洞
- 批准号:
10653834 - 财政年份:2020
- 资助金额:
$ 0.45万 - 项目类别:
Epigenetic Regulation of Drug Resistance to ABT-199 in B-cell Malignancies
B 细胞恶性肿瘤中 ABT-199 耐药性的表观遗传调控
- 批准号:
9904591 - 财政年份:2019
- 资助金额:
$ 0.45万 - 项目类别:
Therapeutic Targeting of Casein Kinase-1-delta in Primary and Metastatic Breast Cancer
酪蛋白激酶-1-δ 在原发性和转移性乳腺癌中的治疗靶向
- 批准号:
10524031 - 财政年份:2018
- 资助金额:
$ 0.45万 - 项目类别:
Therapeutic Targeting of Casein Kinase-1-delta in Primary and Metastatic Breast Cancer
酪蛋白激酶-1-δ 在原发性和转移性乳腺癌中的治疗靶向
- 批准号:
9710619 - 财政年份:2018
- 资助金额:
$ 0.45万 - 项目类别:
Therapeutic Targeting of Casein Kinase-1-delta in Primary and Metastatic Breast Cancer
酪蛋白激酶-1-δ 在原发性和转移性乳腺癌中的治疗靶向
- 批准号:
10064576 - 财政年份:2018
- 资助金额:
$ 0.45万 - 项目类别:
相似国自然基金
跨区域调水工程与区域经济增长:效应测度、机制探究与政策建议
- 批准号:72373114
- 批准年份:2023
- 资助金额:40 万元
- 项目类别:面上项目
农产品区域公用品牌地方政府干预机制与政策优化研究
- 批准号:72373068
- 批准年份:2023
- 资助金额:41 万元
- 项目类别:面上项目
新型城镇化与区域协调发展的机制与治理体系研究
- 批准号:72334006
- 批准年份:2023
- 资助金额:167 万元
- 项目类别:重点项目
我国西南地区节点城市在次区域跨国城市网络中的地位、功能和能级提升研究
- 批准号:72364037
- 批准年份:2023
- 资助金额:28 万元
- 项目类别:地区科学基金项目
多时序CT联合多区域数字病理早期预测胃癌新辅助化疗抵抗的研究
- 批准号:82360345
- 批准年份:2023
- 资助金额:32 万元
- 项目类别:地区科学基金项目
相似海外基金
The Role of Glycosyl Ceramides in Heart Failure and Recovery
糖基神经酰胺在心力衰竭和恢复中的作用
- 批准号:
10644874 - 财政年份:2023
- 资助金额:
$ 0.45万 - 项目类别:
Assessing Native Hawaiian and Pacific Islander Maternal Outcomes and Health Care Experiences
评估夏威夷原住民和太平洋岛民的产妇结局和医疗保健体验
- 批准号:
10644888 - 财政年份:2023
- 资助金额:
$ 0.45万 - 项目类别:
HEAR-HEARTFELT (Identifying the risk of Hospitalizations or Emergency depARtment visits for patients with HEART Failure in managed long-term care through vErbaL communicaTion)
倾听心声(通过口头交流确定长期管理护理中的心力衰竭患者住院或急诊就诊的风险)
- 批准号:
10723292 - 财政年份:2023
- 资助金额:
$ 0.45万 - 项目类别:
Development and implementation of a digital sleep intervention for preschoolers in foster care
为寄养中的学龄前儿童开发和实施数字睡眠干预
- 批准号:
10724304 - 财政年份:2023
- 资助金额:
$ 0.45万 - 项目类别:
Implementing Evidence-Based Treatment for Common Mental Disorders in HIV Clinics in Ukraine
在乌克兰艾滋病毒诊所对常见精神疾病实施循证治疗
- 批准号:
10762576 - 财政年份:2023
- 资助金额:
$ 0.45万 - 项目类别: